Resistance to Tyrosine Kinase Inhibitors - Resistance to Targeted Anti-Cancer Therapeutics -  - Books - Springer International Publishing AG - 9783319460901 - November 14, 2016
In case cover and title do not match, the title is correct

Resistance to Tyrosine Kinase Inhibitors - Resistance to Targeted Anti-Cancer Therapeutics 1st ed. 2016 edition

Price
$ 155.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 14 - 20
Add to your iMusic wish list

Not rated yet

Also available as:

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.


201 pages, 2 black & white illustrations, 6 colour illustrations, 5 colour tables, biography

Media Books     Hardcover Book   (Book with hard spine and cover)
Released November 14, 2016
ISBN13 9783319460901
Publishers Springer International Publishing AG
Pages 188
Dimensions 155 × 235 × 13 mm   ·   462 g
Language German  
Editor Focosi, Daniele

Mere med samme udgiver